 Alan Diekman
Concepts (137)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Semen | 5 | 2014 | 21 | 1.560 |
Why?
| | Galectin 3 | 4 | 2014 | 14 | 1.530 |
Why?
| | Antigens, Neoplasm | 6 | 2014 | 146 | 0.810 |
Why?
| | Spermatozoa | 5 | 2010 | 23 | 0.630 |
Why?
| | Prostate-Specific Antigen | 2 | 2014 | 47 | 0.480 |
Why?
| | Glycoproteins | 4 | 2014 | 115 | 0.430 |
Why?
| | Carrier Proteins | 2 | 2014 | 302 | 0.420 |
Why?
| | Prostate | 1 | 2010 | 117 | 0.340 |
Why?
| | Secretory Vesicles | 1 | 2009 | 12 | 0.340 |
Why?
| | Membrane Glycoproteins | 2 | 2010 | 244 | 0.340 |
Why?
| | Antigens, Surface | 3 | 2007 | 48 | 0.330 |
Why?
| | Antigens, CD | 3 | 2007 | 215 | 0.300 |
Why?
| | Sperm-Ovum Interactions | 3 | 2003 | 4 | 0.280 |
Why?
| | Glycoconjugates | 1 | 2003 | 7 | 0.220 |
Why?
| | Ovum | 1 | 2003 | 6 | 0.220 |
Why?
| | Vaccines, Contraceptive | 1 | 2002 | 1 | 0.210 |
Why?
| | Ligands | 2 | 2014 | 203 | 0.200 |
Why?
| | Molecular Sequence Data | 5 | 2010 | 799 | 0.200 |
Why?
| | Models, Animal | 1 | 2002 | 227 | 0.190 |
Why?
| | Amino Acid Sequence | 4 | 2010 | 579 | 0.180 |
Why?
| | Immunoblotting | 2 | 2011 | 116 | 0.180 |
Why?
| | Protein Binding | 2 | 2014 | 656 | 0.170 |
Why?
| | Tandem Mass Spectrometry | 2 | 2010 | 227 | 0.160 |
Why?
| | Male | 11 | 2014 | 25437 | 0.140 |
Why?
| | Mucin-6 | 1 | 2014 | 1 | 0.120 |
Why?
| | Adipokines | 1 | 2014 | 10 | 0.120 |
Why?
| | Galectins | 1 | 2014 | 5 | 0.120 |
Why?
| | Lectins, C-Type | 1 | 2014 | 30 | 0.120 |
Why?
| | Antibodies, Monoclonal | 3 | 2009 | 457 | 0.110 |
Why?
| | Blood Proteins | 1 | 2014 | 77 | 0.110 |
Why?
| | Acrosome | 2 | 2003 | 4 | 0.110 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2010 | 102 | 0.100 |
Why?
| | Humans | 11 | 2014 | 49898 | 0.100 |
Why?
| | Guinea Pigs | 1 | 2011 | 75 | 0.090 |
Why?
| | Sequence Analysis, Protein | 1 | 2011 | 19 | 0.090 |
Why?
| | Chelating Agents | 1 | 2011 | 28 | 0.090 |
Why?
| | Peptide Mapping | 1 | 2010 | 22 | 0.090 |
Why?
| | Chromatography, Affinity | 1 | 2010 | 38 | 0.090 |
Why?
| | Protease Inhibitors | 1 | 2011 | 58 | 0.090 |
Why?
| | Peptides, Cyclic | 1 | 2010 | 42 | 0.090 |
Why?
| | Zinc | 1 | 2011 | 52 | 0.090 |
Why?
| | Galactosides | 1 | 2009 | 3 | 0.090 |
Why?
| | Ultracentrifugation | 1 | 2009 | 9 | 0.090 |
Why?
| | Centrifugation, Density Gradient | 1 | 2009 | 22 | 0.090 |
Why?
| | Membranes | 1 | 2009 | 16 | 0.090 |
Why?
| | Calcium-Binding Proteins | 1 | 2010 | 54 | 0.090 |
Why?
| | Chromatography, Gel | 1 | 2009 | 39 | 0.090 |
Why?
| | Biotinylation | 1 | 2009 | 26 | 0.090 |
Why?
| | Genitalia, Male | 1 | 2009 | 13 | 0.090 |
Why?
| | Subcellular Fractions | 1 | 2009 | 34 | 0.080 |
Why?
| | Surface Properties | 1 | 2009 | 72 | 0.080 |
Why?
| | Escherichia coli | 2 | 2008 | 191 | 0.080 |
Why?
| | Protein Structure, Tertiary | 1 | 2009 | 249 | 0.080 |
Why?
| | Animals | 5 | 2011 | 13100 | 0.080 |
Why?
| | Cell Membrane | 1 | 2010 | 249 | 0.080 |
Why?
| | Poultry Diseases | 1 | 2008 | 21 | 0.080 |
Why?
| | Escherichia coli Infections | 1 | 2008 | 29 | 0.080 |
Why?
| | Infertility, Male | 1 | 2007 | 12 | 0.070 |
Why?
| | Chickens | 1 | 2008 | 108 | 0.070 |
Why?
| | Polysaccharides | 1 | 2007 | 51 | 0.070 |
Why?
| | Blotting, Western | 3 | 2003 | 587 | 0.070 |
Why?
| | Prostatic Neoplasms | 1 | 2010 | 391 | 0.070 |
Why?
| | Glycosylation | 2 | 2007 | 102 | 0.070 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2008 | 189 | 0.070 |
Why?
| | Species Specificity | 2 | 2003 | 193 | 0.060 |
Why?
| | Bacterial Proteins | 1 | 2008 | 372 | 0.060 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 2003 | 5 | 0.060 |
Why?
| | Glycosylphosphatidylinositols | 1 | 2003 | 32 | 0.050 |
Why?
| | Zona Pellucida | 1 | 2003 | 2 | 0.050 |
Why?
| | Glycocalyx | 1 | 2003 | 2 | 0.050 |
Why?
| | Oviducts | 1 | 2003 | 8 | 0.050 |
Why?
| | Seminal Plasma Proteins | 1 | 2002 | 1 | 0.050 |
Why?
| | Infertility | 1 | 2003 | 17 | 0.050 |
Why?
| | Isoantigens | 1 | 2002 | 9 | 0.050 |
Why?
| | Muramidase | 1 | 2002 | 14 | 0.050 |
Why?
| | Callithrix | 1 | 2002 | 1 | 0.050 |
Why?
| | Contraception, Immunologic | 1 | 2002 | 1 | 0.050 |
Why?
| | Macaca radiata | 1 | 2002 | 1 | 0.050 |
Why?
| | Macaca nemestrina | 1 | 2002 | 2 | 0.050 |
Why?
| | Immunosorbent Techniques | 1 | 2002 | 4 | 0.050 |
Why?
| | Macaca fascicularis | 1 | 2002 | 10 | 0.050 |
Why?
| | Epididymis | 1 | 2002 | 7 | 0.050 |
Why?
| | Papio | 1 | 2002 | 16 | 0.050 |
Why?
| | Pan troglodytes | 1 | 2002 | 11 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2003 | 120 | 0.050 |
Why?
| | Fluorescent Antibody Technique | 1 | 2002 | 112 | 0.050 |
Why?
| | Nuclear Proteins | 1 | 2004 | 242 | 0.050 |
Why?
| | Biological Evolution | 1 | 2002 | 33 | 0.050 |
Why?
| | Epitopes | 1 | 2002 | 59 | 0.050 |
Why?
| | Female | 5 | 2011 | 26560 | 0.040 |
Why?
| | Melanoma | 1 | 2004 | 281 | 0.040 |
Why?
| | Models, Biological | 1 | 2003 | 719 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2002 | 972 | 0.040 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 2 | 2010 | 37 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2008 | 60 | 0.040 |
Why?
| | Sperm Capacitation | 2 | 2010 | 3 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2004 | 145 | 0.030 |
Why?
| | Antibodies | 2 | 2003 | 151 | 0.030 |
Why?
| | Sperm Agglutination | 1 | 2010 | 1 | 0.020 |
Why?
| | Semen Analysis | 1 | 2010 | 1 | 0.020 |
Why?
| | Bacterial Outer Membrane Proteins | 1 | 2008 | 21 | 0.020 |
Why?
| | Calcium | 1 | 2010 | 401 | 0.020 |
Why?
| | Carbohydrate Sequence | 1 | 2007 | 11 | 0.020 |
Why?
| | Mucins | 1 | 2007 | 6 | 0.020 |
Why?
| | Antibody Specificity | 1 | 2007 | 35 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 63 | 0.020 |
Why?
| | Proteomics | 1 | 2008 | 292 | 0.020 |
Why?
| | Spermatids | 1 | 2004 | 3 | 0.010 |
Why?
| | Fertilization | 1 | 2003 | 7 | 0.010 |
Why?
| | Microscopy, Immunoelectron | 1 | 2003 | 13 | 0.010 |
Why?
| | Cytoplasm | 1 | 2004 | 93 | 0.010 |
Why?
| | Antigens, Ly | 1 | 2003 | 11 | 0.010 |
Why?
| | Rats, Inbred Lew | 1 | 2003 | 43 | 0.010 |
Why?
| | Multigene Family | 1 | 2003 | 56 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 1028 | 0.010 |
Why?
| | Cricetinae | 1 | 2003 | 211 | 0.010 |
Why?
| | Cell Nucleus | 1 | 2004 | 186 | 0.010 |
Why?
| | Acetylglucosamine | 1 | 2002 | 6 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2004 | 462 | 0.010 |
Why?
| | Molecular Weight | 1 | 2002 | 85 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2002 | 110 | 0.010 |
Why?
| | Oligosaccharides | 1 | 2002 | 35 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2002 | 81 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2002 | 134 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2002 | 189 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 579 | 0.010 |
Why?
| | Base Sequence | 1 | 2003 | 657 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2002 | 482 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2003 | 347 | 0.010 |
Why?
| | Incidence | 1 | 2004 | 986 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2004 | 1099 | 0.010 |
Why?
| | Young Adult | 1 | 2010 | 4029 | 0.010 |
Why?
| | Ovarian Neoplasms | 1 | 2004 | 450 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2003 | 1578 | 0.010 |
Why?
| | Rats | 1 | 2003 | 3273 | 0.010 |
Why?
| | Mice | 1 | 2003 | 5658 | 0.010 |
Why?
| | Adult | 1 | 2002 | 13346 | 0.000 |
Why?
|
|
Diekman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|